109 related articles for article (PubMed ID: 18670248)
1. Remission of migraine attacks in a patient with depression who is taking pregabalin.
Masdrakis VG; Oulis P; Karakatsanis NA; Potagas C; Kouzoupis AV; Soldatos CR
Clin Neuropharmacol; 2008; 31(4):238-40. PubMed ID: 18670248
[TBL] [Abstract][Full Text] [Related]
2. Substitution of gabapentin therapy with pregabalin therapy in neuropathic pain due to peripheral neuropathy.
Toth C
Pain Med; 2010 Mar; 11(3):456-65. PubMed ID: 20113408
[TBL] [Abstract][Full Text] [Related]
3. Pregabalin drug interaction studies: lack of effect on the pharmacokinetics of carbamazepine, phenytoin, lamotrigine, and valproate in patients with partial epilepsy.
Brodie MJ; Wilson EA; Wesche DL; Alvey CW; Randinitis EJ; Posvar EL; Hounslow NJ; Bron NJ; Gibson GL; Bockbrader HN
Epilepsia; 2005 Sep; 46(9):1407-13. PubMed ID: 16146435
[TBL] [Abstract][Full Text] [Related]
4. Pregabalin in the discontinuation of long-term benzodiazepine use: a case-series.
Oulis P; Masdrakis VG; Karakatsanis NA; Karapoulios E; Kouzoupis AV; Konstantakopoulos G; Soldatos CR
Int Clin Psychopharmacol; 2008 Mar; 23(2):110-2. PubMed ID: 18301126
[TBL] [Abstract][Full Text] [Related]
5. Effects of pregabalin on central sensitization in patients with migraine.
Zhang N; Chen CF; Yu FY
Int J Clin Pharmacol Ther; 2015 Apr; 53(4):277-83. PubMed ID: 25669613
[TBL] [Abstract][Full Text] [Related]
6. Pregabalin-induced parkinsonism: a case report.
Perez Lloret S; Amaya M; Merello M
Clin Neuropharmacol; 2009; 32(6):353-4. PubMed ID: 19952879
[TBL] [Abstract][Full Text] [Related]
7. Pregabalin add-on therapy using a flexible, optimized dose schedule in refractory partial epilepsies: a double-blind, randomized, placebo-controlled, multicenter trial.
Lee BI; Yi S; Hong SB; Kim MK; Lee SA; Lee SK; Shin DJ; Kim JM; Song HK; Heo K; Lowe W; Leon T
Epilepsia; 2009 Mar; 50(3):464-74. PubMed ID: 19222545
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the prophylactic efficacy of amitriptyline and citalopram, alone or in combination, in patients with comorbidity of depression, migraine, and tension-type headache.
Rampello L; Alvano A; Chiechio S; Malaguarnera M; Raffaele R; Vecchio I; Nicoletti F
Neuropsychobiology; 2004; 50(4):322-8. PubMed ID: 15539864
[TBL] [Abstract][Full Text] [Related]
9. Impact of gastrointestinal symptoms on response to pregabalin in generalized anxiety disorder: results of a six-study combined analysis.
Stein DJ; Bruce Lydiard R; Herman BK; Mandel FS
Int Clin Psychopharmacol; 2009 May; 24(3):126-32. PubMed ID: 19352198
[TBL] [Abstract][Full Text] [Related]
10. Relationships among pain and depressive and anxiety symptoms in clinical trials of pregabalin in fibromyalgia.
Arnold LM; Leon T; Whalen E; Barrett J
Psychosomatics; 2010; 51(6):489-97. PubMed ID: 21051680
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive pregabalin for uncontrolled partial-onset seizures: findings from a prospective audit.
Stephen LJ; Parker P; Kelly K; Wilson EA; Leach V; Brodie MJ
Acta Neurol Scand; 2011 Aug; 124(2):142-5. PubMed ID: 21434875
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of pregabalin in patients with epilepsy: the influence of dose, age, and comedication.
May TW; Rambeck B; Neb R; Jürgens U
Ther Drug Monit; 2007 Dec; 29(6):789-94. PubMed ID: 18043477
[TBL] [Abstract][Full Text] [Related]
13. Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome.
Häuser W; Petzke F; Sommer C
J Pain; 2010 Jun; 11(6):505-21. PubMed ID: 20418173
[TBL] [Abstract][Full Text] [Related]
14. A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings.
Gore M; Sadosky A; Tai KS; Stacey B
Clin Ther; 2007 Aug; 29(8):1655-70. PubMed ID: 17919547
[TBL] [Abstract][Full Text] [Related]
15. Fibromyalgia: poorly understood; treatments are disappointing.
Prescrire Int; 2009 Aug; 18(102):169-73. PubMed ID: 19746561
[TBL] [Abstract][Full Text] [Related]
16. Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders.
Tassone DM; Boyce E; Guyer J; Nuzum D
Clin Ther; 2007 Jan; 29(1):26-48. PubMed ID: 17379045
[TBL] [Abstract][Full Text] [Related]
17. The long-term retention of pregabalin in a large cohort of patients with epilepsy at a tertiary referral centre.
Yuen AW; Singh R; Bell GS; Bhattacharjee A; Neligan A; Heaney DC; Duncan JS; Sander JW
Epilepsy Res; 2009 Dec; 87(2-3):120-3. PubMed ID: 19734010
[TBL] [Abstract][Full Text] [Related]
18. Pregabalin in the treatment of chronic migraine: an open-label study.
Calandre EP; Garcia-Leiva JM; Rico-Villademoros F; Vilchez JS; Rodriguez-Lopez CM
Clin Neuropharmacol; 2010; 33(1):35-9. PubMed ID: 19935409
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacotherapy: migraine and depression. Therapy with sumatripten and citalopram: perioperative anaesthesiological risk assessment].
Ittner KP
Anasthesiol Intensivmed Notfallmed Schmerzther; 2006; 41(7-8):464-5. PubMed ID: 16874568
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pregabalin in the treatment of trigeminal neuralgia.
Obermann M; Yoon MS; Sensen K; Maschke M; Diener HC; Katsarava Z
Cephalalgia; 2008 Feb; 28(2):174-81. PubMed ID: 18039340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
